AKTX
Akari Therapeutics·NASDAQ
--
--(--)
--
--(--)
AKTX fundamentals
Akari Therapeutics (AKTX) released its earnings on Aug 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.08 (YoY --), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.08
--
Report date
Aug 13, 2025
Earnings Call
11:00 AM on Aug 18, 2025
Meeting link.EPS
Actual | 0 | 0 | 0 | -0.2 | 0 | 0 | 0 | 0 | 0 | -0.17 | -0.135 | -0.08 | ||||||||||
Forecast | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.2 | -1 | -0.09 | |||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +83.00% | 0.00% | +11.11% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | 0 | 0 | -- | -- | -- | -- | -- | -- | -- | 0 | -- | -- | -- | -- | -- | 0 |
Forecast | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- | -- | -- | 0 | -- | -- | -- | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
Did Akari Therapeutics beat or miss consensus estimates last quarter?What is Akari Therapeutics's gross profit margin?What does Akari Therapeutics do and what are its main business segments?What factors drove the changes in Akari Therapeutics's revenue and profit?What were the key takeaways from Akari Therapeutics's earnings call?What were the key takeaways from Akari Therapeutics’s earnings call?What is Akari Therapeutics's latest dividend and current dividend yield?What guidance did Akari Therapeutics's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
